Non-contrast transcatheter aortic valve implantation for patients with aortic stenosis and chronic kidney disease: a pilot study

被引:4
|
作者
Freire, Antonio Fernando Diniz [1 ]
Nicz, Pedro Felipe Gomes [1 ]
Ribeiro, Henrique Barbosa [1 ]
Filippini, Filippe Barcellos [1 ]
Accorsi, Tarso Duenas [1 ]
Liberato, Gabriela [1 ]
Nomura, Cesar Higa [1 ]
Cassar, Renata de Sa [1 ]
Vieira, Marcelo Luiz Campos [1 ]
Mathias Jr, Wilson [1 ]
Pomerantzeff, Pablo Maria Alberto [1 ]
Tarasoutchi, Flavio [1 ]
Abizaid, Alexandre [1 ]
Kalil Filho, Roberto [1 ]
de Brito Jr, Fabio Sandoli [1 ]
机构
[1] Univ Sao Paulo InCor, Dept Intervent Cardiol, Heart Inst, Sao Paulo, Brazil
来源
关键词
transcatheter aortic valve replacement; aortic stenosis; renal failure; zero contrast; renal insufficiency; OUTCOMES; INJURY; REPLACEMENT; PREDICTORS; IMPACT;
D O I
10.3389/fcvm.2023.1175600
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAcute kidney injury (AKI) is frequently observed after transcatheter aortic valve implantation (TAVI). Of note, it is associated with a threefold increase in all-cause and cardiac death. We propose a new non-contrast strategy for evaluating and performing the TAVI procedure that can be especially valuable for patients with aortic stenosis (AS) and chronic kidney disease (CKD) to prevent AKI. MethodsPatients with severe symptomatic AS and CKD stage & GE;3a were evaluated for TAVI using four non-contrast imaging modalities for procedural planning: transesophageal echocardiogram (TEE), cardiac magnetic resonance, multidetector computed tomography (MDCT), and aortoiliac CO2 angiography. Patients underwent transfemoral (TF) TAVI using the self-expandable Evolut R/Pro, and the procedures were guided by fluoroscopy and TEE. Contrast MDCT and contrast injection at certain checkpoints during the procedure were used in a blinded fashion to guarantee patient safety. ResultsA total of 25 patients underwent TF-TAVI with the zero-contrast technique. The mean age was 79.9 & PLUSMN; 6.1 years, 72% in NYHA class III/IV, with a mean STS-PROM of 3.0% & PLUSMN; 1.5%, and creatinine clearance of 49 & PLUSMN; 7 ml/min. The self-expandable Evolut R and Pro were implanted in 80% and 20% of patients, respectively. In 36% of the cases, the transcatheter heart valve (THV) chosen was one size larger than the one by contrast MDCT, but none of these cases presented adverse events. Device success and the combined safety endpoint (at 30 days) both achieved 92%. Pacemaker implantation was needed in 17%. ConclusionThis pilot study demonstrated that the zero-contrast technique for procedural planning and THV implantation was feasible and safe and might become the preferable strategy for a significant population of CKD patients undergoing TAVR. Future studies with a larger number of patients are still needed to confirm such interesting findings.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Gerakis, Alexandros
    Halapas, Antonios
    Chrissoheris, Michail
    Giatras, Ioannis
    Andritsou, Radostina
    Nikolaou, Ioulia
    Bouboulis, Nikolaos
    Pattakos, Eustratios
    Spargias, Kostas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 366 - 366
  • [42] Impact of Transcatheter Aortic Valve Implantation on Kidney Function: the "Renovalvular" Interaction in Aortic Stenosis
    de Santis, Antonio
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2019, 113 (06) : 1112 - 1113
  • [43] The Treatment of Aortic Valve Stenosis will be Shifted to Transcatheter Aortic Valve Implantation!
    Kuratani, Toru
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (09) : S137 - S138
  • [44] Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis
    Barbanti, M.
    Ussia, G. P.
    Capodanno, D.
    Aruta, P.
    Pistritto, A. M.
    Cammalleri, V.
    Scarabelli, M.
    Del Campo, G.
    Mignosa, C.
    Tamburino, C.
    EUROPEAN HEART JOURNAL, 2011, 32 : 897 - 897
  • [45] FEASIBILITY OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN BICUSPID AORTIC VALVE STENOSIS
    Wood, D. A.
    Wijesinghe, N.
    Nietlispach, F.
    Gurvitch, R.
    Tay, E.
    Rodes-Cabau, J.
    Velianou, J. L.
    Natarajan, M. K.
    Dumont, E.
    Ye, J.
    Leipsic, J.
    Cheung, A.
    Webb, J. G.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 115D - 115D
  • [46] Aortic valve gradient and mortality in patients undergoing transcatheter aortic valve implantation for severe aortic stenosis
    Witberg, G.
    Barbash, I.
    Finkelstein, A.
    Assali, A.
    Segev, A.
    Halkin, A.
    Fefer, P.
    Ben-Shoshan, J.
    Konigstein, M.
    Guetta, V.
    Kornowski, R.
    Barsheshet, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 146 - 146
  • [47] Feasibility of Transcatheter Aortic Valve Implantation in Patients With Very Severe Aortic Stenosis
    Kobayashi, Yoshikuni
    Izumo, Masaki
    Okuyama, Kazuaki
    Uenomachi, Nina
    Shoji, Tatsuro
    Kai, Takahiko
    Okuno, Taishi
    Sato, Yukio
    Kuwata, Shingo
    Koga, Masashi
    Ishibashi, Yuki
    Tanabe, Yasuhiro
    Miyairi, Takeshi
    Akashi, Yoshihiro J.
    CIRCULATION REPORTS, 2023, 5 (09) : 358 - 364
  • [48] Effect of transcatheter aortic valve implantation on QT dispersion in patients with aortic stenosis
    Erkan, Hakan
    Hatem, Engin
    Agac, Mustafa Tarik
    Korkmaz, Levent
    Gokdeniz, Teyyar
    Aykan, Ahmet Cagri
    Kalaycioglu, Ezgi
    Boyaci, Faruk
    Cirakoglu, Omer Faruk
    Celik, Sukru
    JOURNAL OF GERIATRIC CARDIOLOGY, 2014, 11 (04) : 286 - 290
  • [49] Effect of transcatheter aortic valve implantation on QT dispersion in patients with aortic stenosis
    Hakan Erkan
    Engin Hatem
    Mustafa Tank Aga
    Levent Korkmaz
    Teyyar Gkdeniz
    Ahmet CanAykan
    Ezgi Kalaycioglu
    Faruk Boyaci
    mer Faruk Cirakoglu
    Skrelik
    Journal of Geriatric Cardiology, 2014, 11 (04) : 286 - 290
  • [50] Effect of transcatheter aortic valve implantation on QT dispersion in patients with aortic stenosis
    Hakan Erkan
    Engin Hatem
    Mustafa Tank Aga
    Levent Korkmaz
    Teyyar Gkdeniz
    Ahmet CanAykan
    Ezgi Kalaycioglu
    Faruk Boyaci
    mer Faruk Cirakoglu
    Skrelik
    Journal of Geriatric Cardiology, 2014, 11 (04) : 286 - 290